Skip to content
OpenCapital
Get started

Repligen RGEN Europe — Total Assets

Other geography segments

North America
$2.34B+1.5%
APAC
$119.59M+5.1%

Similar metrics at other companies

Watts Water Technologies, Inc. logo
WTSEurope — Total Assets
$629.4M+8.6%
Automatic Data Processing, Inc. logo
ADPEurope — Total Assets
$3.03B+8.0%
Air Products and Chemicals logo
APDEurope — Total Assets
$7.12B+14.5%
Expeditors International of Washington logo
EXPDEurope — Total Assets
$800.82M+3.7%
Fluor logo
FLREurope — Total Assets
$494M-13.0%
Pilgrim's Pride Corporation logo
PPCEurope — Total Assets
$4.25B+2.7%

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×—
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Repligen’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's europe — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's europe — total assets?
Repligen (RGEN) reported europe — total assets of $489.93M in Q4 2025.
How has Repligen's europe — total assets changed year-over-year?
Repligen's europe — total assets increased by 19.4% year-over-year, from $410.28M to $489.93M.
What does europe — total assets mean?
This metric measures the total book value of all resources, including property, equipment, and working capital, controlled by the company within the European geographic segment. It reflects the scale of the company's physical and operational footprint in the region. Investors use this to evaluate the capital intensity required to support European bioprocessing operations and regional growth strategies.